These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15751816)

  • 1. Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort study.
    Ruffatti A; Favaro M; Tonello M; De Silvestro G; Pengo V; Fais G; Suma V; Chiarelli S; Todesco S
    Lupus; 2005; 14(2):120-8. PubMed ID: 15751816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjusted prophylactic doses of nadroparin plus low dose aspirin therapy in obstetric antiphospholipid syndrome. A prospective cohort management study.
    Ruffatti A; Gervasi MT; Favaro M; Ruffatti AT; Hoxha A; Punzi L
    Clin Exp Rheumatol; 2011; 29(3):551-4. PubMed ID: 21640048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature.
    Ruffatti A; Marson P; Pengo V; Favaro M; Tonello M; Bortolati M; Minucci D; De Silvestro G
    Autoimmun Rev; 2007 Jan; 6(3):196-202. PubMed ID: 17289557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
    Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
    Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.
    Yelnik CM; Lambert M; Drumez E; Le Guern V; Bacri JL; Guerra MM; Laskin CA; Branch DW; Sammaritano LR; Morel N; Guettrot-Imbert G; Launay D; Hachulla E; Hatron PY; Salmon JE; Costedoat-Chalumeau N
    Lupus; 2018 Sep; 27(10):1679-1686. PubMed ID: 30016929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies.
    Donohoe S; Quenby S; Mackie I; Panal G; Farquharson R; Malia R; Kingdom J; Machin S
    Lupus; 2002; 11(1):11-20. PubMed ID: 11898913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
    Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study.
    Heilmann L; Schorch M; Hahn T; Adasz G; Schilberz K; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2008 Nov; 34(8):794-802. PubMed ID: 19214917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
    Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
    Front Immunol; 2018; 9():864. PubMed ID: 29867924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
    Simchen MJ; Dulitzki M; Rofe G; Shani H; Langevitz P; Schiff E; Pauzner R
    Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
    Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
    J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.
    Hoxha A; Favaro M; Calligaro A; Del Ross T; Ruffatti AT; Infantolino C; Tonello M; Mattia E; Ruffatti A
    Thromb Haemost; 2020 Jan; 120(1):36-43. PubMed ID: 31634958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of catastrophic antiphospholipid syndrome in a pregnant woman.
    Wislowska M
    Clin Exp Rheumatol; 1999; 17(2):261. PubMed ID: 10342059
    [No Abstract]   [Full Text] [Related]  

  • 14. Obstetric Anti-phospholipid Syndrome: State of the Art.
    Gerardi MC; Fernandes MA; Tincani A; Andreoli L
    Curr Rheumatol Rep; 2018 Aug; 20(10):59. PubMed ID: 30105597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic risk in the antiphospholipid syndrome.
    Lim W
    Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.
    Kwak-Kim J; Agcaoili MS; Aleta L; Liao A; Ota K; Dambaeva S; Beaman K; Kim JW; Gilman-Sachs A
    Am J Reprod Immunol; 2013 Jun; 69(6):596-607. PubMed ID: 23521391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
    Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S
    N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnancy in primary antiphospholipid syndrome. Proposal for a common management protocol].
    el Kouri D; Winer N; Sagot P; Hamidou M; Boog G; Barrier J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(8):828-31. PubMed ID: 9026512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
    Sciascia S; Hunt BJ; Talavera-Garcia E; Lliso G; Khamashta MA; Cuadrado MJ
    Am J Obstet Gynecol; 2016 Feb; 214(2):273.e1-273.e8. PubMed ID: 26429521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin.
    Glasnović M; Bosnjak I; Vcev A; Soldo I; Kosuta M; Lenz B; Glasnović-Horvatić E; Soldo-Butković S; Mićunović N
    Coll Antropol; 2007 Mar; 31(1):173-7. PubMed ID: 17598397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.